AMER2
APC membrane recruitment protein 2
Also known as: AMER2_HUMAN, FAM123A, FLJ25477
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N7J2
- Gene
- AMER2
- Ensembl
- ENSG00000165566
- Chromosome
- 13
- Canonical length
- 671 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Enables phosphatidylinositol-4,5-bisphosphate binding activity. Involved in negative regulation of canonical Wnt signaling pathway. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
671 residues, UniProt reviewed canonical sequence.
>Q8N7J2|AMER2
1 METSRSRGGG GAVSERGGAG ASVGVCRRKA EAGAGTGTLA ADMDLHCDCA AETPAAEPPS
61 GKINKAAFKL FKKRKSGGTM PSIFGVKNKG DGKSSGPTGL VRSRTHDGLA EVLVLESGRK
121 EEPRGGGDSG GGGGGRPNPG PPRAAGPGGG SLASSSVAKS HSFFSLLKKN GRSENGKGEP
181 VDASKAGGKQ KRGLRGLFSG MRWHRKDKRA KAEAAEGRAP GGGLILPGSL TASLECVKEE
241 TPRAAREPEE PSQDAPRDPA GEPAGGEEVP APADRAPARS CREAEGLAHP GDTGARGEDA
301 AGHRRAEPGP GEVRTAEDAS RTGAVPVKTV PLVDSEGGSG RAPAAPDPAS VDPPSDPSAD
361 RICLMFSDVT SLKSFDSLTG CGDIIADQEE EAGPSCDKHV PGPGKPALSK KNPGVVAYQG
421 GGEEMASPDE VDDTYLQEFW DMLSQTEEQG PEPQEGAAKV AAALETKVVP ETPKDTRCVE
481 AAKDASSVKR RRLNRIPIEP HPKEEPKHPE KEQQEGVPNS DEGYWDSTTP GPEEDSSSSG
541 KKAGIPRDSY SGDALYDLYA DPDGSPATLP GGKDNEETSS LSRLKPVSPG TITCPLRTPG
601 SLLKDSKIPI SIKHLTNLPS SHPVVHQQPS RSEMPRTKIP VSKVLVRRVS NRGLAGTTIR
661 ATACHDSAKK LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AMER2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.73
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 35 nTPM
- hippocampal formation: 33 nTPM
- basal ganglia: 32 nTPM
- spinal cord: 28 nTPM
- midbrain: 28 nTPM
- amygdala: 25 nTPM
Single-cell type
- oligodendrocytes: 359 nCPM
- bergmann glia: 344 nCPM
- müller glia: 279 nCPM
- astrocytes: 132 nCPM
- retinal horizontal cells: 106 nCPM
- retinal bipolar cells: 59 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 239 nTPM
- basal ganglia: 155 nTPM
- medulla oblongata: 132 nTPM
- cerebral cortex: 127 nTPM
- thalamus: 110 nTPM
- midbrain: 110 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ectoderm development
- negative regulation of canonical Wnt signaling pathway
- regulation of canonical Wnt signaling pathway
- Wnt signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AMER2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AMER2 as an antibody target. Whether an autoantibody or antibody against AMER2 could matter depends on whether native AMER2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AMER2 is annotated at the cell surface, where native AMER2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AMER2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...